Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-06

Clinical Trial Update: Mirtazapine in Alzheimer-associated Weight Loss

View source ↗

Summary

A completed clinical trial investigates the use of mirtazapine for weight loss associated with Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: Brugmann University Hospital | Conditions: Alzheimer's Disease, Weight Loss | Status: COMPLETED